Novel ACE2 nanoparticles universally block SARS-CoV-2 variants in the human respiratory tract
C. Sauvanet, M. Lemos, A. Bezault, B. Rodriguez de Francisco, M. C. Chan, K. P. Hui, K.-c. Ng, J. M. Nicholls, N. Volkmann, D. Hanein
This study develops hACE2 nanoparticles that block SARS-CoV-2 and its variants by sequestering viruses through aggregation in cell systems and human respiratory tract explants.
bioRxiv · May 5, 2022 · PreprintCell Biology